Belbien 10mg Hemofarm: Short-Term Treatment for Sleep Disorders
The clinical trials conducted to support efficacy of Belbien 10mg Hemofarm lasted up to five weeks, with the last official assessments of sleep latency completed at the end of treatment. This medication is recommended for short-term treatment of sleep disorders in adults, particularly when the sleep disturbance is enervating or causes substantial suffering for the patient.
Therapeutic Uses for Belbien Ambien USA
Belbien (zolpidem Tartrate) tablets are indicated for the short-term treatment of sleep disorders characterized by difficulties with falling asleep. Benzodiazepines or benzodiazepine-like drugs are only advised when the disorder is severe, debilitating, or causing extreme distress.
Belbien Zolpidem Tablets: Dosage and Clinical Trials
Belbien Zolpidem Tablets (zolpidem Tartrate) Oral Spray is used for the short-term treatment of sleep disorders characterized by difficulty initiating sleep. In controlled clinical trials, zolpidem salt was proven to reduce sleep latency for up to 35 days. The clinical trials conducted in support of efficacy lasted 4-5 weeks, with the final formal assessments of sleep latency completed at the end of treatment.
Adult Dosages for Belbien 10mg Hemofarm
The recommended starting dose for women is five milligrams and either five or ten milligrams for men, taken one time every night shortly before the hour with at least 7-8 hours remaining before the scheduled time of rousing. If the five mg dose is ineffective, it will be increased to ten mg. Belbien’s total daily dose should not exceed ten mg immediately before the hour.